These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12124702)

  • 1. Reporting partial screening results: is it confusing and unsatisfactory?
    Mulvey S; Wallace EM
    Prenat Diagn; 2002 Jul; 22(7):633; author reply 633-4. PubMed ID: 12124702
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum screening for anomalies in pregnancy: reasons for acceptance or refusal of the test.
    Gokhale LS; Cietak KA
    J Obstet Gynaecol; 2002 Jul; 22(4):392-3. PubMed ID: 12521462
    [No Abstract]   [Full Text] [Related]  

  • 3. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
    Saller DN; Canick JA
    Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential pathways of testing after first-trimester screening for trisomy 21.
    Malone FD
    Obstet Gynecol; 2005 Feb; 105(2):438; author reply 438-9. PubMed ID: 15684179
    [No Abstract]   [Full Text] [Related]  

  • 5. Are pregnant Australian women well informed about prenatal genetic screening? A systematic investigation using the Multidimensional Measure of Informed Choice.
    Rowe HJ; Fisher JR; Quinlivan JA
    Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):433-9. PubMed ID: 16953859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [-Increased AFP values-].
    Zimmermann R
    Arch Gynecol Obstet; 1995; 256 Suppl():S173-7. PubMed ID: 8619654
    [No Abstract]   [Full Text] [Related]  

  • 7. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects.
    Hoogendoorn M; Evers SM; Schielen PC; van Genugten ML; de Wit GA; Ament AJ
    Community Genet; 2008; 11(6):359-67. PubMed ID: 18690004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost analysis of Down syndrome screening in advanced maternal age.
    Hartnett J; Borgida AF; Benn PA; Feldman DM; DeRoche ME; Egan JF
    J Matern Fetal Neonatal Med; 2003 Feb; 13(2):80-4. PubMed ID: 12735407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient preference regarding first-trimester aneuploidy risk assessment.
    Sharma G; Gold HT; Chervenak FA; McCullough L; Alt AK; Chasen ST
    Am J Obstet Gynecol; 2005 Oct; 193(4):1429-36. PubMed ID: 16202737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow up and evaluation of the Victorian first-trimester combined screening programme for Down syndrome and trisomy 18.
    Jaques AM; Halliday JL; Francis I; Bonacquisto L; Forbes R; Cronin A; Sheffield LJ
    BJOG; 2007 Jul; 114(7):812-8. PubMed ID: 17501960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid aneuploidy test for positive Down screening: who is willing to pay for it?
    Lo TK; Leung WC; Lau WL; Lam H; Lai FK; Ng LS; Wong WC; Chan A; Chin RK
    J Matern Fetal Neonatal Med; 2010 Jul; 23(7):747-9. PubMed ID: 19701862
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for trisomy 21 in Flanders: a 10 years review of 40.490 pregnancies screened by maternal serum.
    Gyselaers WJ; Vereecken AJ; Van Herck EJ; Straetmans DP; Martens GE; de Jonge ET; Ombelet WU; Nijhuis JG
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):185-9. PubMed ID: 15262353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudes of a high-risk group of pregnant Saudi Arabian women to prenatal screening for chromosomal anomalies.
    Babay ZA
    East Mediterr Health J; 2004; 10(4-5):522-7. PubMed ID: 16335642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The prenatal detection of trisomy 13, 18, and 21: comparison of the advanced first trimester screening (AFS) with the first trimester screening according to Nicolaides].
    Hörmansdörfer C; Schmidt P; Hillemanns P; Scharf A
    Z Geburtshilfe Neonatol; 2007 Dec; 211(6):243-9. PubMed ID: 18176905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester combined screening for Down syndrome and other fetal anomalies.
    O'Leary P; Breheny N; Dickinson JE; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Obstet Gynecol; 2006 Apr; 107(4):869-76. PubMed ID: 16582125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analytic study of amniocentesis in prenatal genetic diagnosis. Transversal study of cases].
    Garza Fernández L; Cabra Zurita R; Grether P; García León F; Kably Ambe A
    Ginecol Obstet Mex; 1998 Jun; 66():237-41. PubMed ID: 9679399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prenatal diagnosis and genetic counseling].
    Xia JH; Wu LQ
    Zhonghua Fu Chan Ke Za Zhi; 2003 Aug; 38(8):474-7. PubMed ID: 14627032
    [No Abstract]   [Full Text] [Related]  

  • 19. Ethical considerations of early (first vs. second trimester) risk assessment disclosure for trisomy 21 and patient choice in screening versus diagnostic testing.
    Sharma G; McCullough LB; Chervenak FA
    Am J Med Genet C Semin Med Genet; 2007 Feb; 145C(1):99-104. PubMed ID: 17299736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Method of risk assessment affects acceptance rate of amniocentesis.
    de la Vega A; Verdiales M; Leavitt G
    P R Health Sci J; 2002 Sep; 21(3):233-5. PubMed ID: 12243114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.